Abstract
A 63-year-old man developed a syndrome of cauda equine, with the numbness which is a left lower extremity from the left buttocks, weakness of left leg, and a dysfunction of bladder and bowel. Enhanced MRI revealed the enhancement of lower cauda equine, and a nerve conduction test revealed decreased F-wave persistency in the tibial nerve and increased F-wave latency in the peroneal nerve on the both sides. M-proteinemia was admitted and myeloma was suspected. By a biopsy of a vertebral arch, we diagnosed with diffuse large B-cell lymphoma. We treated with dexamethasone and R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone (prednisolone)), then the symptom was improved. In case of caude equine syndrome with M-proteinemia, a possibility of the malignant lymphoma should also be considered.
Keywords:
M-proteinemia; cauda equine syndrome; diffuse large B cell lymphoma; neurolymphomatosis.
MeSH terms
-
Animals
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Humans
-
Immunoglobulin M / blood*
-
Lymphoma, Large B-Cell, Diffuse / complications*
-
Lymphoma, Large B-Cell, Diffuse / diagnosis*
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / pathology
-
Magnetic Resonance Imaging
-
Male
-
Marek Disease / complications*
-
Marek Disease / diagnosis*
-
Marek Disease / drug therapy
-
Marek Disease / pathology
-
Middle Aged
-
Paraproteinemias / blood*
-
Paraproteinemias / etiology*
-
Polyradiculopathy / diagnostic imaging
-
Polyradiculopathy / etiology*
-
Polyradiculopathy / pathology
-
Positron-Emission Tomography
-
Prednisone / administration & dosage
-
Rituximab
-
Treatment Outcome
-
Vincristine / administration & dosage
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Immunoglobulin M
-
R-CHOP protocol
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone